Agora has been teasing this in all their free or low cost publications. Anyone know whats up??
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
The tedius video is here.
The more skimmable text version is here.
I could be remembering wrong, but I don’t think the video describes the last two triggers.
Profit Trigger #1: Regulatory. FDA approval, etc.
Profit Trigger #2: M&A. Probably spinoffs, carve-outs, and of course upcoming mergers and acquisitions.
Profit Trigger #3: Unexpected Earnings.
Profit Trigger #4: IP. patent rights assignment, etc.
Profit Trigger #5: Uplisting and Delisting. “When shares of a company leap from a small exchange, to something like the NYSE, and a whole new class of investors flood in.”
Anyone know the stock he’s referring to with May 26 fda announcement?